Trials / Recruiting
RecruitingNCT07128186
The Application of an AI-driven Multimodal Predictive Model for Cognitive Impairment in Patients With Type 2 Diabetes Mellitus
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- Tongji Hospital · Academic / Other
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The objective of this observational study is to evaluate the accuracy and feasibility of an artificial intelligence-based multimodal cognitive screening system in early identification of diabetes-related mild cognitive impairment (MCI) among type 2 diabetes mellitus (T2DM) patients through a 3-5 year follow-up. It also aims to analyze the correlation between diabetic metabolic indicators (such as glycemic variability and HbA1c levels) and cognitive function changes, thereby determining the value of this intelligent screening system in early detection and intervention of cognitive impairment in T2DM patients, which constitutes the key focus of this research.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | follow-up observation | In this study, no additional interventions were administered to any enrolled participants; only 3-5 years of follow-up observation were conducted, with cognitive status data collected at both baseline and endpoint. |
Timeline
- Start date
- 2025-04-22
- Primary completion
- 2028-12-30
- Completion
- 2028-12-30
- First posted
- 2025-08-17
- Last updated
- 2025-08-17
Locations
21 sites across 1 country: China
Source: ClinicalTrials.gov record NCT07128186. Inclusion in this directory is not an endorsement.